Ado-trastuzumab emtansine Intravenous and Insulin degludec
Determining the interaction of Ado-trastuzumab emtansine Intravenous and Insulin degludec and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: ado-trastuzumab emtansine
Brand name: Kadcyla
Synonyms: Ado-trastuzumab emtansine, Ado-Trastuzumab Emtansine
Generic Name: insulin degludec
Brand name: Tresiba, Tresiba FlexTouch
Synonyms: Insulin Degludec
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Ado-trastuzumab emtansine Intravenous-Insulin Degludec (U-100) Prefilled Pens
- Ado-trastuzumab emtansine Intravenous-Insulin Degludec (U-100) Vials
- Ado-trastuzumab emtansine Intravenous-Insulin Degludec (U-200) Prefilled Pens
- Ado-trastuzumab emtansine Intravenous-Insulin degludec and liraglutide
- Ado-trastuzumab emtansine Intravenous-Insulin degludec and liraglutide Subcutaneous
- Ado-trastuzumab emtansine Intravenous-Insulin degludec Subcutaneous
- Insulin degludec-Adox Pak 2/100
- Insulin degludec-Adoxa
- Insulin degludec-Adoxa CK
- Insulin degludec-Adoxa Pak
- Insulin degludec-Adoxa Pak 1/100
- Insulin degludec-Adoxa Pak 1/150